Announced Tue, 21 Jul · 11:58 IST
Beta Drugs Q1 FY27 Results Published in Newspapers
Compliance View source PDF
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.4%1-day move
₹2421.00
prior close
₹2462.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1+0.1-0.4-3.4-5.7-3.6-8.0——————
Up moveDown movePending
AI summary
Beta Drugs reported Q1 FY27 standalone profit of Rs 5.93 crore, up about 40 percent YoY, though revenue fell 17 percent to Rs 57.69 crore. Consolidated profit rose 41 percent to Rs 16.49 crore on revenue of Rs 127.13 crore, up 23 percent. EPS stood at Rs 5.55 standalone and Rs 14.78 consolidated. Board approved results on July 20, 2026.
Likely market impact
Profit growth on both standalone and consolidated basis. Standalone margins expanded sharply despite revenue dip.